Cargando…

Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success

BACKGROUND: Renal denervation has no validated marker of procedural success. We hypothesized that successful renal denervation would reduce renal sympathetic nerve signaling demonstrated by attenuation of α‐1‐adrenoceptor‐mediated autotransfusion during the Valsalva maneuver. METHODS AND RESULTS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Saxena, Manish, Shour, Tariq, Shah, Mussadiq, Wolff, Christopher B., Julu, Peter O. O., Kapil, Vikas, Collier, David J., Ng, Fu Liang, Gupta, Ajay, Balawon, Armida, Pheby, Jane, Zak, Anne, Rull, Gurvinder, O'Brien, Benjamin, Schmieder, Roland E., Lobo, Melvin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220552/
https://www.ncbi.nlm.nih.gov/pubmed/29895590
http://dx.doi.org/10.1161/JAHA.118.009151
_version_ 1783368857094717440
author Saxena, Manish
Shour, Tariq
Shah, Mussadiq
Wolff, Christopher B.
Julu, Peter O. O.
Kapil, Vikas
Collier, David J.
Ng, Fu Liang
Gupta, Ajay
Balawon, Armida
Pheby, Jane
Zak, Anne
Rull, Gurvinder
O'Brien, Benjamin
Schmieder, Roland E.
Lobo, Melvin D.
author_facet Saxena, Manish
Shour, Tariq
Shah, Mussadiq
Wolff, Christopher B.
Julu, Peter O. O.
Kapil, Vikas
Collier, David J.
Ng, Fu Liang
Gupta, Ajay
Balawon, Armida
Pheby, Jane
Zak, Anne
Rull, Gurvinder
O'Brien, Benjamin
Schmieder, Roland E.
Lobo, Melvin D.
author_sort Saxena, Manish
collection PubMed
description BACKGROUND: Renal denervation has no validated marker of procedural success. We hypothesized that successful renal denervation would reduce renal sympathetic nerve signaling demonstrated by attenuation of α‐1‐adrenoceptor‐mediated autotransfusion during the Valsalva maneuver. METHODS AND RESULTS: In this substudy of the Wave IV Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension, we enrolled 23 subjects with resistant hypertension. They were randomized either to bilateral renal denervation using therapeutic levels of ultrasound energy (n=12) or sham application of diagnostic ultrasound (n=11). Within‐group changes in autonomic parameters, office and ambulatory blood pressure were compared between baseline and 6 months in a double‐blind manner. There was significant office blood pressure reduction in both treatment (16.1±27.3 mm Hg, P<0.05) and sham groups (27.9±15.0 mm Hg, P<0.01) because of which the study was discontinued prematurely. However, during the late phase II (Iii) of Valsalva maneuver, renal denervation resulted in substantial and significant reduction in mean arterial pressure (21.8±25.2 mm Hg, P<0.05) with no significant changes in the sham group. Moreover, there were significant reductions in heart rate in the actively treated group at rest (6.0±11.5 beats per minute, P<0.05) and during postural changes (supine 7.2±8.4 beats per minute, P<0.05, sit up 12.7±16.7 beats per minute, P<0.05), which were not observed in the sham group. CONCLUSIONS: Blood pressure reduction per se is not necessarily a marker of successful renal nerve ablation. Reduction in splanchnic autotransfusion following renal denervation has not been previously demonstrated and denotes attenuation of (renal) sympathetic efferent activity and could serve as a marker of procedural success. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02029885.
format Online
Article
Text
id pubmed-6220552
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-62205522018-11-15 Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success Saxena, Manish Shour, Tariq Shah, Mussadiq Wolff, Christopher B. Julu, Peter O. O. Kapil, Vikas Collier, David J. Ng, Fu Liang Gupta, Ajay Balawon, Armida Pheby, Jane Zak, Anne Rull, Gurvinder O'Brien, Benjamin Schmieder, Roland E. Lobo, Melvin D. J Am Heart Assoc Original Research BACKGROUND: Renal denervation has no validated marker of procedural success. We hypothesized that successful renal denervation would reduce renal sympathetic nerve signaling demonstrated by attenuation of α‐1‐adrenoceptor‐mediated autotransfusion during the Valsalva maneuver. METHODS AND RESULTS: In this substudy of the Wave IV Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Subjects With Uncontrolled Hypertension, we enrolled 23 subjects with resistant hypertension. They were randomized either to bilateral renal denervation using therapeutic levels of ultrasound energy (n=12) or sham application of diagnostic ultrasound (n=11). Within‐group changes in autonomic parameters, office and ambulatory blood pressure were compared between baseline and 6 months in a double‐blind manner. There was significant office blood pressure reduction in both treatment (16.1±27.3 mm Hg, P<0.05) and sham groups (27.9±15.0 mm Hg, P<0.01) because of which the study was discontinued prematurely. However, during the late phase II (Iii) of Valsalva maneuver, renal denervation resulted in substantial and significant reduction in mean arterial pressure (21.8±25.2 mm Hg, P<0.05) with no significant changes in the sham group. Moreover, there were significant reductions in heart rate in the actively treated group at rest (6.0±11.5 beats per minute, P<0.05) and during postural changes (supine 7.2±8.4 beats per minute, P<0.05, sit up 12.7±16.7 beats per minute, P<0.05), which were not observed in the sham group. CONCLUSIONS: Blood pressure reduction per se is not necessarily a marker of successful renal nerve ablation. Reduction in splanchnic autotransfusion following renal denervation has not been previously demonstrated and denotes attenuation of (renal) sympathetic efferent activity and could serve as a marker of procedural success. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02029885. John Wiley and Sons Inc. 2018-06-12 /pmc/articles/PMC6220552/ /pubmed/29895590 http://dx.doi.org/10.1161/JAHA.118.009151 Text en © 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Saxena, Manish
Shour, Tariq
Shah, Mussadiq
Wolff, Christopher B.
Julu, Peter O. O.
Kapil, Vikas
Collier, David J.
Ng, Fu Liang
Gupta, Ajay
Balawon, Armida
Pheby, Jane
Zak, Anne
Rull, Gurvinder
O'Brien, Benjamin
Schmieder, Roland E.
Lobo, Melvin D.
Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success
title Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success
title_full Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success
title_fullStr Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success
title_full_unstemmed Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success
title_short Attenuation of Splanchnic Autotransfusion Following Noninvasive Ultrasound Renal Denervation: A Novel Marker of Procedural Success
title_sort attenuation of splanchnic autotransfusion following noninvasive ultrasound renal denervation: a novel marker of procedural success
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220552/
https://www.ncbi.nlm.nih.gov/pubmed/29895590
http://dx.doi.org/10.1161/JAHA.118.009151
work_keys_str_mv AT saxenamanish attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT shourtariq attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT shahmussadiq attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT wolffchristopherb attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT julupeteroo attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT kapilvikas attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT collierdavidj attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT ngfuliang attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT guptaajay attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT balawonarmida attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT phebyjane attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT zakanne attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT rullgurvinder attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT obrienbenjamin attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT schmiederrolande attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess
AT lobomelvind attenuationofsplanchnicautotransfusionfollowingnoninvasiveultrasoundrenaldenervationanovelmarkerofproceduralsuccess